Premium
Substituted Xanthones as Antimycobacterial Agents, Part 2: Antimycobacterial Activity
Author(s) -
Pickert Martina,
Schaper Klaus Jürgen,
Frahm August Wilhelm
Publication year - 1998
Publication title -
archiv der pharmazie
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.468
H-Index - 61
eISSN - 1521-4184
pISSN - 0365-6233
DOI - 10.1002/(sici)1521-4184(199805)331:5<193::aid-ardp193>3.0.co;2-s
Subject(s) - antimycobacterial , mycobacterium tuberculosis , minimum inhibitory concentration , mycobacterium smegmatis , chemistry , quantitative structure–activity relationship , tuberculosis , stereochemistry , antibacterial agent , microbiology and biotechnology , in vitro , biology , biochemistry , antibiotics , medicine , pathology
A series of substituted xanthones was tested for their activity against four mycobacterial strains ( Mycobacterium tuberculosis, M. avium, M. lufu, M. smegmatis ) by determination of the minimum inhibitory concentrations (MIC values). For the most active compounds, supplementary characterisation was performed by bacterial growth kinetics, which allows a more precise interpretation of their antimycobacterial effects. From the test set, 1‐methyl‐2,4,7‐trinitroxanthone ( 8a ) showed the highest antimycobacterial activity with a MIC value of 3 μg/mL against M. tuberculosis , which is comparable to the effect of well known drugs used in the treatment of tuberculosis. For all other compounds, the MIC values could not be determined, due to the comparatively low activity and to the poor solubility of the compounds, respectively. The semiquantitative evaluation of activity against the different strains of mycobacteria resulted in a classification into three activity classes, which will be used as dependent parameter in QSAR investigations, to be published in Part 3 of this series.